Ming‐Derg Lai

1.6k total citations
48 papers, 1.3k citations indexed

About

Ming‐Derg Lai is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Ming‐Derg Lai has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 21 papers in Molecular Biology and 13 papers in Immunology. Recurrent topics in Ming‐Derg Lai's work include Cancer-related Molecular Pathways (9 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Research and Treatments (6 papers). Ming‐Derg Lai is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Immunotherapy and Immune Responses (6 papers) and Cancer Research and Treatments (6 papers). Ming‐Derg Lai collaborates with scholars based in Taiwan, United States and Vietnam. Ming‐Derg Lai's co-authors include Su-Lan Wang, Chih‐Yang Wang, Jin‐ding Huang, Jing‐Jane Tsai, Hui‐Ping Hsu, Meng‐Chi Yen, Zhengda Sun, Nam Nhut Phan, Chien‐Fu Chen and Yan‐Shen Shan and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer Research.

In The Last Decade

Ming‐Derg Lai

47 papers receiving 1.3k citations

Peers

Ming‐Derg Lai
Xiao-bo Zhong United States
Xin Wu China
Jiyeon Ahn South Korea
Tian Lan China
Sung Hoo Jung South Korea
Bing Xu China
Xiao-bo Zhong United States
Ming‐Derg Lai
Citations per year, relative to Ming‐Derg Lai Ming‐Derg Lai (= 1×) peers Xiao-bo Zhong

Countries citing papers authored by Ming‐Derg Lai

Since Specialization
Citations

This map shows the geographic impact of Ming‐Derg Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Derg Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Derg Lai more than expected).

Fields of papers citing papers by Ming‐Derg Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Derg Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Derg Lai. The network helps show where Ming‐Derg Lai may publish in the future.

Co-authorship network of co-authors of Ming‐Derg Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Derg Lai. A scholar is included among the top collaborators of Ming‐Derg Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Derg Lai. Ming‐Derg Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ya‐Fang, et al.. (2025). Severe enterovirus A71 pathogenesis and immune responses in human nucleolin transgenic mice. Medical Microbiology and Immunology. 214(1). 30–30.
2.
Hung, Liang‐Yi, et al.. (2024). Inactivation of pentraxin 3 suppresses M2-like macrophage activity and immunosuppression in colon cancer. Journal of Biomedical Science. 31(1). 10–10. 16 indexed citations
3.
Anuraga, Gangga, Chih‐Peng Chang, Hui‐Ping Hsu, et al.. (2023). Repurposing nitric oxide donating drugs in cancer therapy through immune modulation. Journal of Experimental & Clinical Cancer Research. 42(1). 22–22. 36 indexed citations
4.
Wang, Chih‐Yang, Chung-Chieh Chiao, Nam Nhut Phan, et al.. (2020). Gene signatures and potential therapeutic targets of amino acid metabolism in estrogen receptor-positive breast cancer.. PubMed. 10(1). 95–113. 95 indexed citations
5.
Yeh, I‐Jeng, Nam Nhut Phan, Yen‐Hung Wu, et al.. (2020). Gene signatures of SARS-CoV/SARS-CoV-2-infected ferret lungs in short- and long-term models. Infection Genetics and Evolution. 85. 104438–104438. 50 indexed citations
6.
Phan, Nam Nhut, Chih‐Yang Wang, Chien‐Fu Chen, et al.. (2017). Voltage-gated calcium channels: Novel targets for cancer therapy. Oncology Letters. 14(2). 2059–2074. 114 indexed citations
7.
Shan, Yan‐Shen, Hui‐Ping Hsu, Ming‐Derg Lai, et al.. (2017). Cyclin D1 overexpression correlates with poor tumor differentiation and prognosis in gastric cancer. Oncology Letters. 14(4). 4517–4526. 62 indexed citations
8.
Wang, Chih‐Yang, Payam Shahi, John Huang, et al.. (2016). Systematic analysis of the achaete-scute complex-like gene signature in clinical cancer patients. Molecular and Clinical Oncology. 6(1). 7–18. 24 indexed citations
9.
Huang, Tzu‐Ting, Meng‐Chi Yen, Chi‐Chen Lin, et al.. (2011). Skin delivery of short hairpin RNA of indoleamine 2,3 dioxygenase induces antitumor immunity against orthotopic and metastatic liver cancer. Cancer Science. 102(12). 2214–2220. 28 indexed citations
10.
Chen, Shih‐Yao, Chao‐Liang Wu, Ming‐Derg Lai, et al.. (2010). Amelioration of Rat Collagen-Induced Arthritis Through CD4 + T Cells Apoptosis and Synovial Interleukin-17 Reduction by Indoleamine 2,3-Dioxygenase Gene Therapy. Human Gene Therapy. 22(2). 145–154. 29 indexed citations
11.
Shan, Yan‐Shen, Ming‐Derg Lai, Meng‐Chi Yen, et al.. (2010). Establishment of an orthotopic transplantable gastric cancer animal model for studying the immunological effects of new cancer therapeutic modules. Molecular Carcinogenesis. 50(10). 739–750. 15 indexed citations
12.
Chang, Yung‐Sheng, Huan‐Yao Lei, Chiou‐Feng Lin, et al.. (2010). ACSL3 and GSK‐3β are essential for lipid upregulation induced by endoplasmic reticulum stress in liver cells. Journal of Cellular Biochemistry. 112(3). 881–893. 49 indexed citations
13.
Hung, Jui‐Hsiang, Ih‐Jen Su, Hui‐Ching Wang, et al.. (2010). Hepatitis B virus surface antigen interacts with acid alpha‐glucosidase and alters glycogen metabolism. Hepatology Research. 40(6). 633–640. 8 indexed citations
14.
Chen, Yi‐Ling, et al.. (2008). Depletion of CD4+CD25+ regulatory T cells can promote local immunity to suppress tumor growth in benzo[a]pyrene-induced forestomach carcinoma. World Journal of Gastroenterology. 14(38). 5797–5797. 18 indexed citations
15.
Lin, Chi‐Chen, et al.. (2008). Delivery of noncarrier naked DNA vaccine into the skin by supersonic flow induces a polarized T helper type 1 immune response to cancer. The Journal of Gene Medicine. 10(6). 679–689. 25 indexed citations
16.
Wang, Hui‐Ching, Wen‐Tsan Chang, Wen‐Wei Chang, et al.. (2005). Hepatitis B virus pre‐S2 mutant upregulates cyclin A expression and induces nodular proliferation of hepatocytes†. Hepatology. 41(4). 761–770. 108 indexed citations
17.
Wang, Su-Lan, et al.. (1999). G169R Mutation Diminishes the Metabolic Activity of CYP2D6 in Chinese. Drug Metabolism and Disposition. 27(3). 385–388. 43 indexed citations
18.
Huang, Wei, et al.. (1997). The Inducible Lactose Operator-Repressor System Is Functional in the Whole Animal. DNA and Cell Biology. 16(1). 17–22. 13 indexed citations
19.
Li, Yuling, et al.. (1995). Overexpression of MDM‐2 mRNA and mutation of the p53 tumor suppressor gene in bladder carcinoma cell lines. Molecular Carcinogenesis. 13(3). 173–181. 34 indexed citations
20.
Chang, Wen‐Chang, et al.. (1993). Partial reversion of transformed phenotype of B104 cancer cells by antisense nucleic acids. Cancer Letters. 69(1). 27–32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026